 The purpose of this study is to find out the effects of a drug called LBH589 when given to people with recurrent or refractory Hodgkin or Non-Hodgkins lymphoma. The safety of this drug will also be studied. The participants physical state, changes in the size of the tumor, or state of Hodgkin or non-Hodgkins Lymphoma, and laboratory findings taken while on-study will help the researchers decide if LBH589 is safe and effective. 